Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors

Meili Zhang, Zhengsheng Yao, Zhuo Zhang, Kayhan Garmestani, Carolyn K. Goldman, Jeffrey V. Ravetch, John Edward Janik, Martin W. Brechbiel, Thomas A. Waldmann

Research output: Contribution to journalArticle

28 Scopus citations

Fingerprint Dive into the research topics of 'Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds